Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 2 (JAK2), particularly in the development of treatments for myeloproliferative disorders. Shows promising activity against JAK2-dependent cell lines, helping suppress abnormal cell proliferation associated with certain blood cancers. Also investigated for anti-inflammatory applications due to its role in cytokine signaling pathways. Its structure allows for high target specificity, making it a valuable scaffold in optimizing kinase inhibitors with improved efficacy and reduced off-target effects.